Purchase Order 36C24225P1466

Award Date 9/3/25
Potential Completion Date 9/3/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a $49,748.73 firm fixed-price purchase order for the delivery of Novocure's Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is not set aside and is issued under...
This is a $49,748.73 firm fixed-price federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The award is structured as a purchase order under Novocure's existing 5-year, $28.85...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $33,165.82, is a firm fixed-price purchase order for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma. The contract does not have a set-aside designation,...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is part of Novocure's Federal Supply Schedule...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the rental of Optune Plus Transducers, which utilize Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order. It is not...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, with a ceiling value of $49,748.73, is for the provision of Optune Plus Transducers, a proprietary medical device system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is a delivery order under...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, identified as 36F79723D0016|36C24725N0794, is for the provision of the Optune Plus Transducer medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract has a ceiling value of...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Transducer, a device that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract has a firm fixed price and an ultimate...

This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a firm fixed-price purchase order for the delivery of Novocure's Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract has a ceiling value of $49,748.73 and a completion date of September 3, 2025. The contract is not designated as a set-aside. Novocure is the prime contractor and will directly provide its proprietary medical technologies without utilizing subcontractors. The contract is part of Novocure's larger $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which enables VA Integrated Service Networks to issue delivery orders for the company's innovative cancer treatment technologies.

Generated 9/4/25, 9:49 AM